Primary ovarian insufficiency. [PDF]
Brent S, Christakis M, Shirreff L.
europepmc +10 more sources
The role of anti-Müllerian hormone: insights into ovarian reserve, primary ovarian insufficiency, and menopause prediction. [PDF]
This review highlights the role of Anti-Müllerian Hormone (AMH) in ovarian insufficiency and as a predictor of menopause. AMH, produced by granulosa cells in growing follicles, is a key marker of ovarian reserve, reflecting the remaining pool of viable ...
Karaviti E +7 more
europepmc +2 more sources
Primary ovarian insufficiency: update on clinical and genetic findings. [PDF]
Primary ovarian insufficiency (POI) is a disorder of insufficient ovarian follicle function before the age of 40 years with an estimated prevalence of 3.7% worldwide.
Federici S +6 more
europepmc +2 more sources
Autoimmune Disease is Increased in Women With Primary Ovarian Insufficiency.
Context Autoimmune disease is common in women with primary ovarian insufficiency (POI), and the genetic etiology of autoimmune disease suggests that it could be hereditary in families of women with POI.
Wang V +7 more
europepmc +2 more sources
Searching for the 'X' factor: investigating the genetics of primary ovarian insufficiency. [PDF]
Primary ovarian insufficiency (POI) is the cessation of ovarian function before the age of 40. The causes of POI are heterogeneous, but substantial evidence exists to support a genetic basis of POI, particularly in the critical involvement of genes on ...
Knight A, Sugin S, Jurisicova A.
europepmc +2 more sources
Identification of genetically engineered strategies to manipulate nano-platforms presenting immunotherapeutic ligands for alleviating primary ovarian insufficiency progression. [PDF]
Primary ovarian insufficiency (POI) is a pathological condition characterized by the early loss of functional ovarian follicles, leading to infertility and systemic consequences affecting reproductive, skeletal, cardiovascular, and neurocognitive helath.
Zhou G +6 more
europepmc +2 more sources
The Role of Cellular Senescence in Cyclophosphamide-Induced Primary Ovarian Insufficiency. [PDF]
Young female cancer patients can develop chemotherapy-induced primary ovarian insufficiency (POI). Cyclophosphamide (Cy) is one of the most widely used chemotherapies and has the highest risk of damaging the ovaries. Recent studies elucidated the pivotal
Xu Z +11 more
europepmc +2 more sources
Breast Cancer Is Increased in Women With Primary Ovarian Insufficiency.
Context DNA damage/repair gene variants are associated with both primary ovarian insufficiency (POI) and cancer risk. Objective We hypothesized that a subset of women with POI and family members would have increased risk for cancer.
Allen-Brady K +11 more
europepmc +2 more sources
Homozygosity for a stop-gain variant in CCDC201 causes primary ovarian insufficiency. [PDF]
Age at menopause (AOM) has a substantial impact on fertility and disease risk. While many loci with variants that associate with AOM have been identified through genome-wide association studies (GWAS) under an additive model, other genetic models are ...
Oddsson A +41 more
europepmc +2 more sources
Primary Ovarian Insufficiency, Bone Health, and Other Outcomes in Adolescents. [PDF]
Adolescents with primary ovarian insufficiency (POI) frequently present with arrested pubertal development or amenorrhea. Early evaluation of menstrual irregularities can avoid a delayed diagnosis.
Cipres DT, Gordon CM.
europepmc +2 more sources

